Literature DB >> 3835554

Time course of the intrahepatic lesion of extrahepatic biliary atresia: a morphometric study.

B H Landing, T R Wells, E Ramicone.   

Abstract

The time course of the intrahepatic lesions of untreated extrahepatic biliary atresia was evaluated by morphometric analysis of 49 specimens from 27 patients. The data show an early phase of rapid bile ductular proliferation, with peak in this material at 205 days, followed by rapid duct regression to approximately 400 days, and slower progressive intrahepatic duct loss thereafter. The ratio of ducts to connective tissue in portal tracts follows a similar course. Connective tissue in portal tracts rises on a slower course and continues to increase after maximum duct regression is reached, so the ratio of parenchyma to fibrous septa falls over the later course of the process. Although duct and connective tissue proliferation in hepatic portal tracts is associated in many liver diseases, the data of this study demonstrate dissociability of the relationships, with the fibrosis in the later stages of the intrahepatic process in extrahepatic biliary atresia apparently neither responsive to nor inducing biliary ductular proliferation.

Entities:  

Mesh:

Year:  1985        PMID: 3835554     DOI: 10.3109/15513818509026904

Source DB:  PubMed          Journal:  Pediatr Pathol        ISSN: 0277-0938


  10 in total

1.  Design and validation of an early scoring system for predicting early outcomes of type III biliary atresia after Kasai's operation.

Authors:  Chen Zhen; Qiao Guoliang; Ma Lishuang; Zhang Zhen; Wang Chen; Zhang Jun; Liu Shuli; Guan Kaoping; Liu Chao; Yang Xuan; Li Long
Journal:  Pediatr Surg Int       Date:  2015-04-18       Impact factor: 1.827

2.  The dendritic cell-T helper 17-macrophage axis controls cholangiocyte injury and disease progression in murine and human biliary atresia.

Authors:  Celine S Lages; Julia Simmons; Avery Maddox; Keaton Jones; Rebekah Karns; Rachel Sheridan; Shiva Kumar Shanmukhappa; Sujit Mohanty; Matthew Kofron; Pierre Russo; Yui-Hsi Wang; Claire Chougnet; Alexander G Miethke
Journal:  Hepatology       Date:  2016-11-10       Impact factor: 17.425

3.  Usefulness of a scoring system in the interpretation of histology in neonatal cholestasis.

Authors:  Way Seah Lee; Lai Meng Looi
Journal:  World J Gastroenterol       Date:  2009-11-14       Impact factor: 5.742

4.  Fishing for biliary atresia susceptibility genes.

Authors:  Alexander G Miethke; Stacey S Huppert
Journal:  Gastroenterology       Date:  2013-03-22       Impact factor: 22.682

Review 5.  Biliary atresia: recent progress.

Authors:  Mikelle D Bassett; Karen F Murray
Journal:  J Clin Gastroenterol       Date:  2008-07       Impact factor: 3.062

6.  Analysis of the histologic features in the differential diagnosis of intrahepatic neonatal cholestasis.

Authors:  Maria Angela Bellomo-Brandao; Cecilia A F Escanhoela; Luciana R Meirelles; Gilda Porta; Gabriel Hessel
Journal:  World J Gastroenterol       Date:  2009-01-28       Impact factor: 5.742

Review 7.  Neonatal Cholestasis - Differential Diagnoses, Current Diagnostic Procedures, and Treatment.

Authors:  Thomas Götze; Holger Blessing; Christian Grillhösl; Patrick Gerner; André Hoerning
Journal:  Front Pediatr       Date:  2015-06-17       Impact factor: 3.418

8.  Extrahepatic biliary atresia: Correlation of histopathology and liver function tests with surgical outcomes.

Authors:  Lucky Gupta; Siddhartha D Gupta; Veereshwar Bhatnagar
Journal:  J Indian Assoc Pediatr Surg       Date:  2012-10

9.  CD 56 staining in liver biopsies does not help in differentiating extrahepatic biliary atresia from other causes of neonatal cholestasis.

Authors:  Fatemeh E Mahjoub; Reza Hadizadeh Khairkhah; Mehri Najafi Sani; Guiti Irvanloo; Maryam Monajemzadeh
Journal:  Diagn Pathol       Date:  2008-03-05       Impact factor: 2.644

10.  Diversity of disorders causing neonatal cholestasis - the experience of a tertiary pediatric center in Germany.

Authors:  André Hoerning; Simon Raub; Alexander Dechêne; Michelle N Brosch; Simone Kathemann; Peter F Hoyer; Patrick Gerner
Journal:  Front Pediatr       Date:  2014-06-23       Impact factor: 3.418

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.